|
|||||
|
|
Targeting the NANOG/HDAC1 axis reverses resistance to PD-1 blockade by reinvigorating the antitumor immunity cycle |
|
| Authors: | Se Jin Oh Hyo-Jung Lee Kwon-Ho Song Suyeon Kim Eunho Cho Jaeyoon Lee Marcus W. Bosenberg Tae Woo Kim |
| Abstract: | |
| Keywords: | Oncology Therapeutics |